AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Biotechnology

Healthcare
$5.82 +2.48%

+$0.25 today

Market cap
$286.62M
Beta
2.62
P/E (TTM)
-7.1
EPS (TTM)
-$1.28
52W Low $8.75High $17.45

Volume 0.13M

Average 0.14M

AGMB Intangible Assets

Identifiable non-physical assets such as patents, trademarks, licenses, and customer relationships.

AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB

Intangible Assets · Q3 FY2025 · quarter ended Sep 2025

Intangible assets of €20.11M in Q3 FY2025

Q3 FY2025 intangible assets was €20.11M.

Context

  • Intangible assets amounted to 12.1% of total assets at the end of Q3 FY2025.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2025
€20.11M— QoQ
Intangible Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Intangible Assets history

Currency unavailable · from the balance sheet

No Intangible Assets data reported for this period type.

Intangible Assets vs competitors

How AGMB compares with its peers on the latest reported figures

  • Peers report in different currencies, so intangible assets is compared through growth and share of total assets rather than absolute size.
  • Intangible assets amounts to 12.1% of total assets for AGMB, versus a peer median of 0.0%.
AGMB Competitors
Intangible Assets for AGMB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€20.11M EUR——12.1%
ALMSAlumis Inc. Common StockJun 2026$9.14M USD-82.1%—1.6%
ANABAnaptysBio, Inc.Mar 2026$0 USD——0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 USD——0.0%
EQEquillium, Inc.Mar 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding AGMB) —-82.1%—0.0%

Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

AgomAb Therapeutics N.V. American Depositary Shares

NASDAQ:AGMB

Intrinsic Alpha fair value

Locked

Current Price

$5.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.